<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04703296</url>
  </required_header>
  <id_info>
    <org_study_id>20201488</org_study_id>
    <secondary_id>W81XWH20C0065</secondary_id>
    <nct_id>NCT04703296</nct_id>
  </id_info>
  <brief_title>Mindfulness Training in Special Operations Forces (SOF) Candidates</brief_title>
  <official_title>Mindfulness Training in Special Operations Forces (SOF) Candidates</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Miami</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>United States Department of Defense</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Miami</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The overarching goal of this study is to develop, deliver, and investigate the utility and&#xD;
      feasibility of train-the-trainer delivery of mindfulness training (MT) in support of improved&#xD;
      readiness (across cognitive, affective, and social domains of the human dimension) and&#xD;
      improve retention of candidates in the SOF qualification pipeline at the U.S. Army John F.&#xD;
      Kennedy Special Warfare Center and School (referred to as SWCS).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 1, 2022</start_date>
  <completion_date type="Anticipated">May 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">May 1, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Attentional Performance</measure>
    <time_frame>Baseline to week 5.</time_frame>
    <description>Attentional Performance as measured by the Sustained Attention Response Task (SART). SART has a range of scores from 0 to 1 with a higher score indicating better accuracy of completing the task.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Working Memory Performance</measure>
    <time_frame>Baseline to week 5.</time_frame>
    <description>Working Memory Performance as measured by the Working Memory Task with Affective Distracters (WMDA). WMDA has a range of scores from 0 to 100%, with higher scores indicating better accuracy on the task.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Cognitive Failures</measure>
    <time_frame>Baseline to week 5.</time_frame>
    <description>Cognitive Failures will be measured by the Cognitive Failures Questionnaire (CFQ). CFQ has total score ranging from 0 to 100, with a higher score indicating more cognitive failures.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Positive Affect</measure>
    <time_frame>Baseline to week 5.</time_frame>
    <description>Positive Affect will be measured by the Positive and Negative Affect Schedule (PANAS-10). The PANAS Positive has a range of scores from 5 to 25, with higher score indicating higher positive mood.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Negative Affect</measure>
    <time_frame>Baseline to week 5.</time_frame>
    <description>Negative Affect will be measured by the Positive and Negative Affect Schedule (PANAS-10). The PANAS Negative has a range of scores from 5 to 25, with higher score indicating higher negative mood.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Perceived Stress</measure>
    <time_frame>Baseline to week 5.</time_frame>
    <description>The short version of the Perceived Stress Scale (PSS) will be used assess perceived stress. The 4-item PSS has a range of scores from 0 to 16, with higher score indicating higher level of perceived stress.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Psychological Health</measure>
    <time_frame>Baseline to week 5.</time_frame>
    <description>Patient Health Questionnaire (PHQ-4) will be used to assess depression and anxiety. PHQ-4 has a range of scores from 0 to 12, with higher scores indicating higher level of depression and anxiety.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Post-Traumatic Stress Disorder (PTSD) symptomatology</measure>
    <time_frame>Baseline to week 5.</time_frame>
    <description>Post-traumatic Stress Disorder Checklist for military populations (PCL-M) will be used to measure symptoms of PTSD. PCL-M has a range of scores from 17 to 85, with higher scores indicating more PTSD symptoms.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Emotion Regulation</measure>
    <time_frame>Baseline to week 5.</time_frame>
    <description>The short version of the Difficulties in Emotion Regulation Scale (DERS) will be used to assess difficulties in emotion regulation. DERS has a range of scores from 18 to 90, with higher scores indicating more difficulties in regulating emotions.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Perspective Taking</measure>
    <time_frame>Baseline to week 5.</time_frame>
    <description>The Perspective Taking Subscale from the Interpersonal Reactivity Index (IRI) will be used to assess perspective taking. The Perspective Taking Subscale has a range of score 0 to 28, with a higher score indicating greater perspective taking.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Cognitive Change</condition>
  <arm_group>
    <arm_group_label>MBAT group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in the Mindfulness-Based Attention Training (MBAT) group will receive 4 weeks of the MBAT course.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>NTC group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Participants in the no-training control (NTC) group will not receive any intervention.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>MBAT course</intervention_name>
    <description>The MBAT will involve:&#xD;
(i) 4 weekly 2-hour course sessions. The sessions will provide guided exercises, didactic information, and discussions to promote greater mindfulness.&#xD;
(ii) Daily mindfulness practice that will be facilitated by the Measuring Mindfulness App (MMA) and/or instructor-delivered mindfulness practices. The daily mindfulness practice will require about 15 minutes to complete.</description>
    <arm_group_label>MBAT group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Individuals who are between 18 and 65 years of age.&#xD;
&#xD;
          -  Individuals who are fluent English speakers.&#xD;
&#xD;
          -  Individuals who are active-duty service members.&#xD;
&#xD;
          -  Men and women of all races and ethnicities.&#xD;
&#xD;
          -  Individuals who are willing and able to consent to participate in the study.&#xD;
&#xD;
          -  Individuals who are attending Special Warfare Center and School (SWCS).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Individuals who have a medical or neurological condition that might interfere with&#xD;
             performance on the task in the study (e.g., epilepsy)&#xD;
&#xD;
          -  Individuals with a history of hospitalization for psychological/mental health issues&#xD;
             within the last 6 months.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Amishi Jha</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Miami</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ekaterina Denkova</last_name>
    <phone>3052848148</phone>
    <email>exn67@miami.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Miami</name>
      <address>
        <city>Coral Gables</city>
        <state>Florida</state>
        <zip>33146</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Ekaterina Denkova</last_name>
      <phone>305-284-8148</phone>
      <email>exn67@miami.edu</email>
    </contact>
    <investigator>
      <last_name>Amishi Jha</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>January 7, 2021</study_first_submitted>
  <study_first_submitted_qc>January 7, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 11, 2021</study_first_posted>
  <last_update_submitted>June 9, 2021</last_update_submitted>
  <last_update_submitted_qc>June 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Miami</investigator_affiliation>
    <investigator_full_name>Amishi Jha</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Stress</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

